Amy E. Tapper is Chief & Technical Operations at Imago BioSciences, Inc. (IMGO). They have made 6 open-market trades across 1 company since 2022, most recently 2023-01-11.
CIK 0001861069
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 6 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| IMGO | 127,315 | $4.6M |
Shares reported on the most recent Form 4, priced at the 2023-01-05 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| IMGO | SELL | 2022-12-16 | 2022-12-20 | $35.78 | $7.2M | +0.3% | N/A | N/A |
| IMGO | SELL · 10b5-1 | 2022-11-02 | 2022-11-04 | $17.90 | $13K | +8.6% | +120.9% | N/A |
| IMGO | SELL | 2022-08-12 | 2022-08-16 | $19.22 | $456K | -17.8% | -13.7% | -6.0% |
| IMGO | SELL · 10b5-1 | 2022-07-20 | 2022-07-21 | $17.90 | $13K | -21.3% | -11.2% | -18.9% |
| IMGO | SELL | 2022-02-11 | 2022-02-15 | $23.78 | $71K | -1.8% | -16.8% | -36.9% |
| IMGO | SELL | 2022-02-09 | 2022-02-11 | $21.54 | $65K | -5.4% | -17.3% | -43.8% |
| IMGO | SELL | 2022-02-01 | 2022-02-03 | $19.72 | $242K | +22.9% | +10.8% | -12.8% |
| IMGO | SELL | 2022-01-12 | 2022-01-14 | $19.96 | $120K | -3.5% | +26.3% | +2.1% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.